July 12, 2022
Three families in three different states all share one thing in common – their children were diagnosed with spina bifida in utero.
Through their journey to find help, the families were referred to Ramesha Papanna, MD, a maternal-fetal surgeon with McGovern Medical School at UTHealth Houston and The Fetal Center at Children's Memorial Hermann Hospital, where they enrolled in a one-of-a-kind fetoscopic spina bifida study using cryopreserved umbilical cord.
June 30, 2022
Researchers at UTHealth School of Public Health have been selected to receive $1 million from a $3.4 million grant to address the opioid epidemic and identify overdose patterns.
June 29, 2022
Providing caregivers easy access to produce and flexible resources can lead to improvements in kids’ diets in a short time, according to a new study co-authored by researchers with UTHealth School of Public Health together with researchers from Dell Medical School at The University of Texas at Austin.
June 28, 2022
As a stay-at-home father of three, Jordan Gonzales was determined to tackle his Type 2 diabetes to be a healthy and present parent.
June 22, 2022
Daily use of a mushroom extract supported the immune system in clearing human papillomavirus (HPV) infections, according to researchers with UTHealth Houston. The study was published today in Frontiers in Oncology.
June 17, 2022
In 2014, a dysautonomia diagnosis led 6-year-old Hannah Haisler of Belton, Texas, to Mohammed T. Numan, MD, with the Dysautonomia Center for Excellence at UTHealth Houston. Today, the 14-year-old is playing competitive volleyball and bungee jumping, thanks to the care she received.
June 16, 2022
A new study shows targeting a protein in smooth muscle cells can block and decrease buildup of atherosclerotic plaque in mouse models, according to researchers with UTHealth Houston.
June 15, 2022
Some patients with obstructive sleep apnea (OSA) who don’t respond to traditional therapy are benefiting from an alternative option being offered at UTHealth Houston.
May 31, 2022
Adults infected with COVID-19 develop circulating antibodies that last for nearly 500 days, according to a new study led by researchers at UTHealth School of Public Health.
The findings were published in The Journal of Infectious Diseases.
May 26, 2022
Three generations of Jon Huffman’s family have suffered Huntington’s disease – a rare, inherited, ultimately fatal disease that causes the progressive breakdown of nerve cells in the brain and is best known for the associated involuntary movements, as well as cognitive and psychiatric symptoms. So it didn’t come as a particular surprise to Jon or Patricia Huffman, his wife of 36 years, when Jon began showing symptoms of the neurodegenerative disorder around 2007.
